Cargando…

Troponin: a risk marker beyond heart disease

Detalles Bibliográficos
Autores principales:	De Palma, Rodney, Meier, Pascal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2014
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4189252/ https://www.ncbi.nlm.nih.gov/pubmed/25332776 http://dx.doi.org/10.1136/openhrt-2013-000009

Ejemplares similares

The diagnostic role of cardiac troponin I beyond acute myocardial infarction
por: Wong, Peter S. C., et al.
Publicado: (2023)

Diagnostic Utility of High Sensitivity Troponins for Echocardiographic Markers of Structural Heart Disease
por: Wang, Tom Kai Ming, et al.
Publicado: (2018)

Novel Biomarkers for Risk Stratification and Identification of Life-threatening Cardiovascular Disease: Troponin and Beyond
por: Razzouk, Louai, et al.
Publicado: (2012)

Inflammatory markers and mediators in heart disease
por: Valdes, Ana M., et al.
Publicado: (2018)

Septic Shock and Troponin I: Are They in a Relationship?
por: Gupta, Sachin, et al.
Publicado: (2019)

Prognostic Biomarkers in Acute Coronary Syndromes: Risk Stratification Beyond Cardiac Troponins
por: Eggers, K. M., et al.
Publicado: (2017)

Troponin Variants as Markers of Skeletal Muscle Health and Diseases
por: Rasmussen, Monica, et al.
Publicado: (2021)

High-Sensitivity Cardiac Troponin, Statin Therapy, and Risk of Coronary Heart Disease
por: Ford, Ian, et al.
Publicado: (2016)

Biomarkers of acute myocardial infarction in the elderly: troponin and beyond
por: Rains, Martin G, et al.
Publicado: (2014)

High‐Sensitivity Cardiac Troponin: From Patient Phenotypes to Clinical Events in Patients With Heart Failure With Preserved Ejection Fraction
por: Bozkurt, Biykem
Publicado: (2018)

Elevated Cardiac Troponin in Clinical Scenarios Beyond Obstructive Coronary Artery Disease
por: Sternberg, Michael, et al.
Publicado: (2019)

The relevance of periprocedural troponin rise: the never ending story!
por: Fröhlich, Georg Marcus, et al.
Publicado: (2017)

Severe Symptomatic Aortic Stenosis? Check Troponin, Too
por: Charitakis, Konstantinos, et al.
Publicado: (2019)

Familial history of heart disease and increased risk for elevated troponin in apparently healthy individuals
por: Cohen, Noa, et al.
Publicado: (2019)

Actin-associated proteins and cardiomyopathy—the ‘unknown’ beyond troponin and tropomyosin
por: Ehler, Elisabeth
Publicado: (2018)

Addition of heart score to high-sensitivity troponin T versus conventional troponin T in risk stratification of patients with chest pain at the coronary emergency rooms
por: Willems, M. N. I., et al.
Publicado: (2014)

Troponin elevation in patients with non-obstructive coronary artery disease: just a bystander or life threatening?
por: Sinning, Christoph, et al.
Publicado: (2023)

Troponin measurement in routine clinical practice: the reality behind the guidelines
por: Collinson, Paul
Publicado: (2022)

Relevance of Troponin I Elevation among Individuals with Hypertensive Emergency
por: Maheshwarappa, Harish Mallapura, et al.
Publicado: (2022)

Troponin in non-cardiac department—finding a stray piece of puzzle?
por: Urbanowicz, Tomasz
Publicado: (2023)

TROPONIN CORRELATES WITH INFLAMMATORY MARKERS IN COVID-19
por: Klinkhammer, Brent, et al.
Publicado: (2021)

Role for Cystatin C–Based Risk Stratification for Patients After Acute Coronary Syndrome in the Era of High Sensitivity Cardiac Troponin Assays
por: Latta, Federica, et al.
Publicado: (2018)

New high-sensitivity troponin test reduces heart attack risk
Publicado: (2018)

Mind the gap versus filling the gap. The heart beyond specialties
por: Pascual, Isaac, et al.
Publicado: (2021)

Benefits of SGLT2 Inhibitor: Preventing Heart Failure and Beyond
por: Kim, Yong Sook, et al.
Publicado: (2019)

Chronic Heart Failure: Diagnosis and Management beyond LVEF Classification
por: Triposkiadis, Filippos, et al.
Publicado: (2022)

NT-proBNP, troponin I and troponin T are elevated in ARDS patients without structural heart disease: a single initial reading of cardiac markers is not different from serial daily readings
por: Nassar, Y, et al.
Publicado: (2011)

Serum Cardiac Troponin-I is Superior to Troponin-T as a Marker for Left Ventricular Dysfunction in Clinically Stable Patients with End-Stage Renal Disease
por: Buiten, Maurits S., et al.
Publicado: (2015)

Heart rate – A complex prognostic marker in acute heart failure
por: Olligs, Jan, et al.
Publicado: (2019)

Beyond the Valve: Lifelong Management of Right Ventricular Outflow Tract Lesion in Adult Congenital Heart Disease
por: Lee, Chang-Ha
Publicado: (2022)

Diagnosis of acute myocardial infarction: highlighting cardiac troponins as vital biomarkers
por: Pourali, Ali, et al.
Publicado: (2023)

Chest Pain: Who Needs Additional Testing Beyond ECG and Troponin?
por: Makhija, Rakhee, et al.
Publicado: (2021)

Biomarkers of HFpEF: Natriuretic Peptides, High-Sensitivity Troponins and Beyond
por: Morfino, Paolo, et al.
Publicado: (2022)

DNA Damage in Chronic Heart Failure: Consequences Beyond those in the Heart
por: Corrêa, Camila Renata, et al.
Publicado: (2020)

Is Electrocardiography‐Left Ventricular Hypertrophy an Obsolete Marker for Determining Heart Failure Risk With Hypertension?
por: Ferdinand, Keith C., et al.
Publicado: (2019)

Cardiovascular screening of athletes during the COVID-19 pandemic: The (ir)relevance of elevated cardiac troponins
por: Van De Heyning, Caroline M., et al.
Publicado: (2021)

Value of Troponin Testing for Detection of Heart Disease in Previously Healthy Children
por: Dionne, Audrey, et al.
Publicado: (2020)

Diabetes and Heart Failure in Patients With Coronary Disease: Separating Markers From Mediators
por: McGuire, Darren K., et al.
Publicado: (2010)

High-sensitivity troponin assays and the early rule-out of acute myocardial infarction
por: Shah, Anoop S V, et al.
Publicado: (2013)

Contemporary point of care cardiac troponin testing in suspected acute coronary syndrome
por: Chapman, Andrew R, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_dirg8jt0d95crgs0fvd1uhar75